Sclerosis |
|
|
Clinical Trial: A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis
This study is not yet open for patient recruitment.
Verified by University of Strasbourg January 2007
|
Purpose
| Condition |
|---|
| Amyotropic Lateral Sclerosis |
MedlinePlus consumer health information
Study Type: Observational
Study Design: Natural History, Longitudinal, Case Control, Prospective Study
Official Title: A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis.
Eligibility
Inclusion Criteria:
- patients with definite ALS
- male or female
- age > 18
Exclusion Criteria:
- patients with other neuromuscular affections
Location and Contact Information
France
Clinique Neurologique, Service des maladies du système nerveux et du muscle, Hôpital Civil, Hôpitaux Universitaires, Strasbourg, 67091, France
Yon-Andoni Echanz-Laguna, MD, Principal Investigator, Hopitaux Universitaires de Strasbourg
More Information
Last Updated: January 17, 2007
Record first received: September 13, 2005
ClinicalTrials.gov Identifier: NCT00213824
Health Authority: France: Afssaps - French Health Products Safety Agency
ClinicalTrials.gov processed this record on May 08, 2007

Not Signed In -


